Skip to main content

Research Repository

Advanced Search

Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy

Podlasek, Anna; Claire, Ravinder; Campbell, Katarzyna A.; Orton, Sophie; Thomson, Ross; Coleman, Tim

Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy Thumbnail


Authors

Anna Podlasek

Ravinder Claire

SOPHIE ORTON SOPHIE.ORTON@NOTTINGHAM.AC.UK
Senior Research Fellow

TIM COLEMAN tim.coleman@nottingham.ac.uk
Professor of Primary Care



Abstract

Aims: To determine effects of concurrent smoking and nicotine replacement therapy (NRT) use on reported heaviness of smoking, nicotine (cotinine) body fluid and exhaled air carbon monoxide (CO) concentrations. Methods: Systematic review and meta‐analysis of RCTs, which test interventions permitting concurrent NRT use and smoking and comparing, within participants, outcomes when smoking with those when smoking and using NRT concurrently. Measurements included reported number of cigarettes smoked per day (CPD), body fluid cotinine and expired air CO concentrations. Results: Twenty‐nine studies were included in the review. Meta‐analysis of nine showed that, compared with when solely smoking, fewer cigarettes were smoked daily when NRT was used (mean difference during concurrent smoking and NRT use, −2.06 CPD [95% CI = −3.06 to −1.07, P < 0.0001]). Meta‐analysis of seven studies revealed a non‐significant reduction in exhaled CO during concurrent smoking and NRT use (mean difference, −0.58 ppm [95% CI = −2.18 to 1.03, P = 0.48]), but in the three studies that tested NRT used in the lead‐up to quitting (i.e. as preloading), a similar reduction in exhaled CO was statistically significant (mean difference, −2.54 ppm CO [95% CI = −4.14 to −0.95, P = 0.002]). Eleven studies reported cotinine concentrations, but meta‐analysis was not possible because of data reporting heterogeneity; of these, seven reported lower cotinine concentrations with concurrent NRT use and smoking, four reported no differences, and none reported higher concentrations. Conclusions: People who smoke and also use nicotine replacement therapy report smoking less heavily than people who solely smoke. When nicotine replacement therapy is used in the lead‐up to quitting (preloading), this reported smoking reduction has been biochemically confirmed. There is no evidence that concurrent smoking and nicotine replacement therapy use result in greater nicotine exposure than solely smoking.

Citation

Podlasek, A., Claire, R., Campbell, K. A., Orton, S., Thomson, R., & Coleman, T. (2023). Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy. Addiction, 118(11), 2076-2092. https://doi.org/10.1111/add.16279

Journal Article Type Article
Acceptance Date May 16, 2023
Online Publication Date Jul 2, 2023
Publication Date 2023-11
Deposit Date Jul 29, 2023
Publicly Available Date Aug 1, 2023
Journal Addiction
Print ISSN 0965-2140
Electronic ISSN 1360-0443
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 118
Issue 11
Pages 2076-2092
DOI https://doi.org/10.1111/add.16279
Keywords preloading, nicotine, smoking, cotinine, carbon monoxide, nicotine replacement therapy, reduction, meta‐analysis
Public URL https://nottingham-repository.worktribe.com/output/22714186
Publisher URL https://onlinelibrary.wiley.com/doi/10.1111/add.16279

Files





You might also like



Downloadable Citations